
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $3.5B | -- | -- | $9.58 | -- |
08/05/2025 | Q2 | $3B | -- | -- | $1.77 | -- |
05/07/2025 | Q1 | $2.5B | $2.1B | -$14.35 | -$5.95 | -$8.40 |
02/11/2025 | Q4 | $2.7B | $2.7B | -$55.66 | -$0.76 | -$54.90 |
10/31/2024 | Q3 | $3.5B | $3.4B | $6.65 | $8.15 | -$1.50 |
08/05/2024 | Q2 | $3.1B | $3B | $0.41 | $2.61 | -$2.20 |
05/01/2024 | Q1 | $2.5B | $2.5B | -$3.21 | -$2.53 | -$0.68 |
02/12/2024 | Q4 | $2.8B | $2.8B | $7.10 | $4.12 | $2.98 |
11/01/2023 | Q3 | -- | -- | $16.78 | $14.19 | $2.59 |
07/31/2023 | Q2 | -- | -- | $11.01 | $9.40 | $1.61 |
05/01/2023 | Q1 | -- | -- | $7.72 | $3.35 | $4.37 |
02/13/2023 | Q4 | -- | -- | $10.10 | $6.99 | $3.11 |
10/31/2022 | Q3 | -- | -- | $21.67 | $14.64 | $7.03 |
08/01/2022 | Q2 | -- | -- | $15.71 | $11.83 | $3.88 |
05/02/2022 | Q1 | -- | -- | $9.71 | $3.54 | $6.17 |
02/14/2022 | Q4 | -- | -- | $6.63 | $6.07 | $0.56 |
11/01/2021 | Q3 | -- | -- | $10.45 | $6.68 | $3.77 |
08/03/2021 | Q2 | -- | -- | $5.63 | $2.56 | $3.07 |
05/03/2021 | Q1 | -- | -- | -$2.43 | -$1.96 | -$0.47 |
02/16/2021 | Q4 | -- | -- | -$1.29 | -$0.68 | -$0.61 |
10/29/2020 | Q3 | -- | -- | $0.63 | $0.47 | $0.16 |
07/28/2020 | Q2 | -- | -- | -$6.91 | -$5.68 | -$1.23 |
05/04/2020 | Q1 | -- | -- | -$2.16 | -$1.83 | -$0.33 |
02/19/2020 | Q4 | -- | -- | $1.90 | $0.50 | $1.40 |
10/31/2019 | Q3 | -- | -- | $2.50 | $3.64 | -$1.14 |
08/05/2019 | Q2 | -- | -- | $0.81 | $0.74 | $0.07 |
05/01/2019 | Q1 | -- | -- | -$1.20 | -$1.00 | -$0.20 |
02/20/2019 | Q4 | -- | -- | $0.16 | -- | -- |
11/05/2018 | Q3 | -- | -- | $2.68 | -- | -- |
08/07/2018 | Q2 | -- | -- | $0.32 | -- | -- |
05/02/2018 | Q1 | -- | -- | -$1.08 | -- | -- |
02/21/2018 | Q4 | -- | -- | $2.65 | -- | -- |
11/06/2017 | Q3 | -- | -- | $2.91 | -- | -- |
08/07/2017 | Q2 | -- | -- | $0.04 | -- | -- |
05/03/2017 | Q1 | -- | -- | -$1.25 | -- | -- |
02/16/2017 | Q4 | -- | -- | -$0.35 | -- | -- |
11/02/2016 | Q3 | -- | -- | $2.28 | -- | -- |
08/02/2016 | Q2 | -- | -- | $0.38 | -- | -- |
05/03/2016 | Q1 | -- | -- | -$0.53 | -- | -- |
02/24/2016 | Q4 | -- | -- | -$0.06 | -- | -- |
11/03/2015 | Q3 | -- | -- | $1.77 | -- | -- |
Avis Budget Group reported $2.1B worth of top line sales in its most recent quarter.
Avis Budget Group announced earnings per share of -$14.35 which represents a miss of analyst forecast a -$5.95 per share.
Avis Budget Group reported $1.2B that represents $33.10 per share over the last quarter.
Avis Budget Group's earnings are forecast to decrease from -$51.23 per share to $4.99 per share next year representing a decrease of -88.15%.
Avis Budget Group's next earnings date is August 5, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.